Burning Rock Biotech Ltd ADR [BNR] stock prices are up 41.42% to $8.24 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BNR shares have gain 79.13% over the last week, with a monthly amount glided 144.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Burning Rock Biotech Ltd ADR [BNR] has been fluctuating between $2.18 and $7.90 over the past year. Burning Rock Biotech Ltd ADR [NASDAQ: BNR] shares were valued at $8.24 at the most recent close of the market.
Analyzing the BNR fundamentals
The Burning Rock Biotech Ltd ADR [NASDAQ:BNR] reported sales of 72.48M for trailing twelve months, representing a surge of 4.65%. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at -0.47%, Pretax Profit Margin comes in at -0.44%, and Net Profit Margin reading is -0.46%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.39 and Total Capital is -0.41. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.21 points at the first support level, and at 4.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.87, and for the 2nd resistance point, it is at 11.51.
Ratios To Look Out For
It’s worth pointing out that Burning Rock Biotech Ltd ADR [NASDAQ:BNR]’s Current Ratio is 3.02. In addition, the Quick Ratio stands at 2.76 and the Cash Ratio stands at 1.96. Considering the valuation of this stock, the price to sales ratio is 1.03, the price to book ratio is 1.12.
